O'Connor Daniel J. - Insider Non-Derivative Transactions at Ambrx Biopharma, Inc. (AMAM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 7, 2024, O'Connor Daniel J.'s relationship to Ambrx Biopharma, Inc. (AMAM) is Director,Officer (President and CEO), and currently has 2,750,000 shares of Ordinary Shares, and 0 shares of Common Stock.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AMAM insiders.
Data Source: SEC.
O'Connor Daniel J. - Insider Non-Derivative Transactions of AMAM Common Stock
O'Connor Daniel J. - Insider Non-Derivative Transactions at AMAM
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Mar 8, 2024 | Disposition -- (Common Stock) | 48202 | 0 | 0 |
Dec 12, 2023 | Acquisition -- (Common Stock) | 750000 | 0 | 1363332 |
Oct 28, 2023 | Sell -- (Common Stock) | 50012 | 9.82 | 342845 |
Apr 27, 2023 | Acquisition -- (Ordinary Shares) | 2750000 | 0 | 2750000 |